{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:37:43Z","timestamp":1787841463146,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Analysis of prescription patterns and lipid profiles can play a crucial role in rational drug use and patient safety. This study aimed to analyze the prescription pattern and impact of statin in lipid profile among ischemic heart disease (IHD) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>A prospective observational study was conducted for 7 months in the cardiology department. IHD patients above 18 years and undergoing statin therapy for at least 3 months were enrolled. Patients with elevated liver enzymes and unfit for statin therapy, pregnant women, psychiatry patients, and critically ill subjects were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of the total participants, 214 (71.8%) were males and 84 (28.2%) were females, with a mean age of 62.55 \u00b1 9.56 years. The most common age group diagnosed with IHD was between 60 and 69 years. Hypertension was observed in 64.4% of the patients, while diabetes was present in 55.7% as the most commonly associated comorbidities. The majority of patients (75.8%) received atorvastatin. The prescription pattern for various drug classes included proton pump inhibitors (93%), antiplatelet agents (82.2%), statins (82.2%), nitrates (60.4%), beta-blockers (34.6%), diuretics (16.8%), biguanides (17.4%), and insulin (15.1%). After 3 months of statin therapy, a statistically significant change was observed in the lipid profile (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Statin agents were the most frequently prescribed class of drugs, followed by antiplatelets. Significant improvements were observed in the lipid profile after a 3-month course of statin therapy. Effective therapeutic monitoring can significantly impact a positive health outcome in patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jehp.jehp_1164_23","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:00:09Z","timestamp":1720789209000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of prescription pattern and impact of statin in lipid profile among ischemic heart disease patients"],"prefix":"10.4103","volume":"13","author":[{"given":"Sagar Kunnaruvath","family":"Prabhakaran","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala Bahadur","family":"Rawal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaraj","family":"Utagi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, KS Hegde Medical Academy, Justice KS Hegde Charitable Hospital, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Venkat","family":"Mateti","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, KS Hegde Medical Academy, Nitte (Deemed to be University), Deralakatte, Mangaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ehjqcco\/qcaa076","article-title":"Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990\u20132017: Results from the global burden of disease study 2017","volume":"8","author":"Dai","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.aogh.2016.04.002","article-title":"Trends in coronary heart disease epidemiology in India","volume":"82","author":"Gupta","year":"2016","journal-title":"Ann Glob Health"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4330\/wjc.v4.i4.112","article-title":"Regional variations in cardiovascular risk factors in India: India heart watch","volume":"4","author":"Gupta","year":"2012","journal-title":"World J Cardiol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4236\/wjcs.2021.1111015","article-title":"Lipid profile of coronary heart disease patients: A prospective observational study","volume":"11","author":"Alam","year":"2021","journal-title":"World J Cardiovasc Surg"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2042098612474293","article-title":"Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy","volume":"4","author":"Lowe","year":"2013","journal-title":"Ther Adv Drug Saf"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"e001972","DOI":"10.1136\/openhrt-2022-001972","article-title":"Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment","volume":"9","author":"Gynnild","year":"2022","journal-title":"Open Heart"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2016.07.001","article-title":"Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan","volume":"251","author":"Teramoto","year":"2016","journal-title":"Atherosclerosis"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ehj.2012.08.005","article-title":"Lipid profile in Egyptian participants with coronary artery disease","volume":"65","author":"Ibrahim","year":"2013","journal-title":"Egypt Heart J"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3329\/dujps.v20i3.59799","article-title":"Factors affecting the prescription pattern of generic cardiovascular medicines: A cross-sectional study in Dhaka City","volume":"20","author":"Sultana","year":"2022","journal-title":"Dhaka Univ J Pharm Sci"},{"key":"R12-20240828","first-page":"26","article-title":"Drug utilization pattern in cardiovascular diseases: A descriptive study in tertiary care settings in Pakistan","volume":"7","author":"Zafar","year":"2015","journal-title":"J Bioequiv Availab"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.1993.tb04183.x","article-title":"Bridging the gap between clinical pharmacology and rational drug prescribing","volume":"35","author":"Ramsay","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"R14-20240828","first-page":"308","article-title":"Drug utilisation study in a tertiary care center: Recommendations for improving hospital drug dispensing policies","volume":"76","author":"Mittal","year":"2014","journal-title":"Indian J Pharm Sci"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/jcpc.jcpc_22_21","article-title":"To study the prescription patterns and adequacy of use of statins at a tertiary care center of North India","volume":"10","author":"Khanal","year":"2021","journal-title":"J Clin Prev Cardiol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12872-020-01835-0","article-title":"Lipid profile and prognosis in patients with coronary heart disease: A meta-analysis of prospective cohort studies","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"R17-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2042098612474293","article-title":"Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy","volume":"4","author":"Lowe","year":"2013","journal-title":"Therapeutic advances in drug safety"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"7537510","DOI":"10.1155\/2022\/7537510","article-title":"Low-density lipoprotein cholesterol levels in coronary artery disease patients: Opportunities for improvement","volume":"2022","author":"Martin","year":"2022","journal-title":"Cardiol Res Pract"},{"key":"R19-20240828","first-page":"502","article-title":"Analysis of trends and characteristics of mortality of ischemic heart disease over the age of 35 years old in China, 2004\u20132011","volume":"48","author":"Liu","year":"2014","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7324\/JAPS.2016.60521","article-title":"Lipid profile of the coronary heart disease (CHD) patients admitted in a hospital in Malaysia","volume":"6","author":"Haque","year":"2016","journal-title":"J App Pharm Sci"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12944-020-01340-5","article-title":"The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: A one-year follow-up observational study","volume":"19","author":"Qiu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/ham.2010.1050","article-title":"Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet","volume":"12","author":"Sherpa","year":"2011","journal-title":"High Alt Med Biol"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.18203\/2319-2003.ijbcp20192644","article-title":"Study of drug prescription pattern in ischemic heart disease patients","volume":"8","author":"Sawant","year":"2019","journal-title":"Int J Basic Clin Pharmacol"},{"key":"R24-20240828","first-page":"e43319","article-title":"Effects of different types of statins on lipid profile: A perspective on Asians","volume":"15","author":"Meor Anuar Shuhaili","year":"2017","journal-title":"Int J Endocrinol Metab"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1177\/1741826711424567","article-title":"Twenty-year trends in cardiovascular risk factors in India and influence of educational status","volume":"19","author":"Gupta","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"R26-20240828","first-page":"24","article-title":"Prescribing pattern in coronary artery disease: A prospective study","volume":"3","author":"Dawalji","year":"2014","journal-title":"Int J Pharm Res Rev"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"e0169826","DOI":"10.1371\/journal.pone.0169826","article-title":"Use of proton-pump inhibitors predicts heart failure and death in patients with coronary artery disease","volume":"12","author":"Pello L\u00e1zaro","year":"2017","journal-title":"PLoS One"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","article-title":"Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American heart association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11886-011-0220-3","article-title":"The role of triglycerides in atherosclerosis","volume":"13","author":"Talayero","year":"2011","journal-title":"Curr Cardiol Rep"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5455\/medarh.2016.70.261-264","article-title":"Studying the relation of postprandial triglyceride with coronary artery disease (CAD)","volume":"70","author":"Manochehri","year":"2016","journal-title":"Med Arch"}],"container-title":["Journal of Education and Health Promotion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1164_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:55:52Z","timestamp":1787838952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jehp.jehp_1164_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jehp.jehp_1164_23","relation":{},"ISSN":["2277-9531","2319-6440"],"issn-type":[{"value":"2277-9531","type":"print"},{"value":"2319-6440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"2023-08-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}